Switch View
© PR Newswire
16.09.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East
News Preview
The Memorandum of Understanding includes the formation of a Joint Venture in the Kingdom of Saudi Arabia for manufacturing and distribution of the Company's upcoming Co-Dx™ PCR platform and other Co-Dx IP
SALT LAKE CITY, Sept. 16, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission in connection with the Company’s pending merger with Alcon (SIX/NYSE: ALC). S...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: KR7328130000
Lunit Inc.
328130
LISTED
KOE
Lunit Showcases AI-Powered Cancer Ecosystem at APEC High-Level Meeting on Health and the Economy and World Bio Summit 2025
News Preview
Lunit highlights global leadership in cancer AI alongside world health experts with dedicated APEC HLMHE session and WBS 2025 Leaders' Dialogue
SEOUL, South Korea, Sept. 16, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced its participation in two major global health gat...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
16.09.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring
News Preview
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today launched the Welch Allyn Connex 360 Vital Signs Monitor, its next generation patient monitoring device. As the latest innovation in Baxter’s connected monitoring portfolio, Connex 360 offers an advanced connectivity and security platform, customizable configurations base...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
16.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lost Money on Lantheus Holdings, Inc.(LNTH)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus Holdings, Inc." or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit.
CLASS DEFINITION: Th...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
Investors in RxSight, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in RxSight, Inc. ("RxSight, Inc." or the "Company") (NASDAQ: RXST) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to r...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Levi & Korsinsky Notifies Shareholders of Nutex Health Inc.(NUTX) of a Class Action Lawsuit and an Upcoming Deadline
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit se...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Alto Neuroscience, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ANRO
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Alto Neuroscience, Inc. ("Alto Neuroscience, Inc." or the "Company") (NYSE: ANRO) of a class action securities lawsuit.
CLASS DEFINITION: The...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 28, 2025 to Discuss Your Rights - SMLR
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit.
CLASS DEFINITION: Th...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 25, 2025 to Discuss Your Rights - LFMD
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the "Company") (NASDAQ: LFMD) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to rec...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
November 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SVRA
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recov...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & Korsinsky
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. ("Unicycive Therapeutics, Inc." or the "Company") (NASDAQ: UNCY) of a class action securities lawsuit.
CLASS DEFI...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
16.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
Replimune Group, Inc. Class Action: Levi & Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - REPL
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ("Replimune Group, Inc." or the "Company") (NASDAQ: REPL) of a class action securities lawsuit.
CLASS DEFINITION: The la...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US29405E2081
Enveric Biosciences, Inc.
ENVB
LISTED
NASDAQ
Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission
News Preview
Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced that it has received a written response from the U.S. Food and Drug Administration (FDA) to its request for a Pre-Investigational New...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels
News Preview
Tandem Diabetes Care® (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today announced the publication of a study, "Adults with Type 2 Diabetes Benefit from Automated Insulin Delivery Irrespective of C-peptide Level," in the American Diabetes Association’s Diabetes Care. The study, a sub-analysis from the 2IQP randomized,...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC LEI: 5493003YBCY4W1IMJU04 NET ASSET VALUE The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 15 September 2025 was 349.21p (cum income). For and on behalf of the B...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US44148G2049
Hoth Therapeutics, Inc.
HOTH
LISTED
NASDAQ
Hoth Therapeutics Issues Shareholder Update: HT-001, HT-KIT, Expanded Treasury Reserve Strategy, and VA Obesity Program Drive Strongest Position in Company History
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, today announced a comprehensive shareholder update, underscoring momentum across its lead clinical programs and corporate strategy. With HT-001 advancing globally, HT-KIT achieving key validation milestones, the expansion o...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US54948X1090
Lucid Diagnostics Inc.
LUCD
LISTED
NASDAQ
Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs
News Preview
Scelfo to strengthen and scale Lucid's market access infrastructure ahead of key upcoming reimbursement milestones—including Medicare coverage for EsoGuard—and to accelerate commercial coverage expansion
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage cancer prevention...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US9467841055
Waystar Holding Corp.
WAY
LISTED
NASDAQ
Waystar Advances AI Leadership with Next-Generation Denial Prevention and Reimbursement Recovery Innovations
News Preview
Tackling $20 billion lost in denial recovery efforts and $17 billion in uncompensated care, helping providers unlock stronger financial performance and resilience
LEHI, Utah and LOUISVILLE, Ky., Sept. 16, 2025 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today will unveil breakthrough innovations at it...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US22407B1089
Coya Therapeutics, Inc.
COYA
LISTED
NASDAQ
Coya Therapeutics' COYA 303 Shows Promising Central Nervous System (CNS) Anti-inflammatory Effects and Systemic Regulatory T Cell (Treg) Enhancing Effects in a Preclinical Animal Inflammation Model
News Preview
COYA 303 is an investigational proprietary combination of LD-IL-2 and GLP-1RA for subcutaneous administration, under development for the treatment of diseases, including Alzheimer's Disease, driven by chronic and sustained inflammation;
COYA 303 demonstrated significant attenuation of neuroinflammation in cortex and hippocampus brain regions and...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US46266C1053
IQVIA Holdings Inc
IQV
LISTED
NYSE
IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships
News Preview
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has been honored with the WCG Pinnacle Award for Site Relationships in Professionalism and Communication. The award recognizes IQVIA’s commitment to building strong, collaborativ...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US8740602052
Takeda Pharmaceutical Company
TAK
LISTED
NYSE
Takeda and VELA to Ship Medicines Across the Atlantic Using First-of-its-Kind Wind-Powered Trimaran
News Preview
Takeda (TSE:4502/NYSE:TAK) and VELA Transport today announced their business partnership, with Takeda set to become the first biopharmaceutical company to transport its products between Europe and the U.S. using VELA’s first-of-its-kind sailing cargo trimaran. VELA designed and will operate a fleet of new generation sailing cargo vessels, powered...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: CH0432492467
Alcon AG
ALC
LISTED
NYSE
Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with UNITY VCS
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced results from time and motion studies demonstrating superior efficiency* with UNITY® Vitreoretinal Cataract System (VCS) for vitreoretinal and cataract surgery compared to CONSTELLATION® Vision System and CENTURION® Vision System with ACTIVE...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: INE0DK501011
Piramal Pharma Limited
PPLPHARMA
LISTED
BSE
Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
News Preview
This tablet press will provide the facility's Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery. Piramal Pharma Solutions has implemented robust training protocols to ensure safe operation and high-quality output from the XM-12. MUMBAI, India, Sept. 16, 2025 /PRNewswire/...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: INE0DK501011
Piramal Pharma Limited
PPLPHARMA
LISTED
BSE
Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
News Preview
This tablet press will provide the facility's Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery. Piramal Pharma Solutions has implemented robust training protocols to ensure safe operation and high-quality output from the XM-12. MUMBAI, India, Sept. 16, 2025 /PRNewswire/...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: INE0DK501011
Piramal Pharma Limited
PPLPHARMA
LISTED
BSE
Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
News Preview
This tablet press will provide the facility's Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery. Piramal Pharma Solutions has implemented robust training protocols to ensure safe operation and high-quality output from the XM-12. MUMBAI, India, Sept. 16, 2025 /CNW/ -- Pira...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: CA92767B1058
Vireo Growth Inc
VREO
LISTED
CSE
Vireo Growth Inc. Announces Launch of Adult-Use Cannabis Sales in Minnesota
News Preview
– Company now dispensing adult-use cannabis at all eight Green Goods® dispensaries in Minnesota –...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US1598641074
Charles River Laboratories International Inc
CRL
LISTED
NYSE
Charles River Laboratories Announces Chief Financial Officer Transition
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that Flavia H. Pease, Corporate Executive Vice President and Chief Financial Officer (CFO), has resigned from her role, effective September 29, 2025, to pursue another opportunity. Following Ms. Pease’s departure, Michael G. Knell, Corporate Senior Vice President and Chief...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US23283X2062
Cytosorbents Corp
CTSO
LISTED
NASDAQ
CytoSorbents Provides DrugSorb-ATR Regulatory Update
News Preview
PRINCETON, N.J., Sept. 16, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today provided a regulatory update on DrugSorb™-ATR....
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: CA23344H1091
DRI Healthcare Trust
DHT.U
LISTED
TSX
DRI Healthcare to Present at Upcoming Investor Conferences
News Preview
TORONTO, Sept. 16, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare"), a global leader in providing financing to advance innovation in the life sciences industry, today announced that it will present at the following investor conferences in September and October:...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US75955J4022
Relmada Therapeutics Inc
RLMD
LISTED
NASDAQ
Relmada Regains Compliance with Nasdaq Minimum Bid Price Requirement
News Preview
CORAL GABLES, Fla., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology-related and central nervous system indications, today announced that on September 15, 2025 it received written notice from the Nasdaq Stock...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US03969K1088
Arcutis Biotherapeutics Inc
ARQT
LISTED
NASDAQ
Allure Magazine Honors Arcutis’ ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough Award
News Preview
Allure Magazine Honors Arcutis’ ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough Award...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US91307C1027
United Therapeutics Corp
UTHR
LISTED
NASDAQ
United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum
News Preview
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Martine Rothblatt, Ph.D., Chairperson and Chief Executive Officer, will provide an overview and update on the company during a fireside chat session at the Bernstein 2nd Annual Healthcare Forum in New York.
The session will take place on Tuesday, S...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US45784P1012
Insulet Corp
PODD
LISTED
NASDAQ
Insulet Announces CFO Transition
News Preview
Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Flavia Pease will succeed Ana Maria Chadwick as Executive Vice President, Chief Financial Officer, effective September 30, 2025. Ms. Chadwick will become a Senior Advisor t...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: IT0004147952
Newron Pharmaceuticals SpA
NWRN
LISTED
SIX
Newron presents H1 2025 results and provides business update
News Preview
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced its financial results and operational highlights for the half-year ended June 30, 2025, and provided a business update f...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
Bristol Myers Squibb to Participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum
News Preview
Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum on Tuesday, September 23, 2025.
The company will take part in a fireside chat beginning at 9:40 a.m. ET.
Investors and the general public are invited to listen to the sess...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US71944F1066
Phreesia, Inc.
PHR
LISTED
NYSE
Becker’s Names Phreesia’s Sara DiNardo as one of 2025’s Rising Stars of Healthcare
News Preview
Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Sara DiNardo, Vice President of Client Solutions, has been named in Becker’s Hospital Review’s 2025 list of Rising Stars: 100 Healthcare Leaders Under 40.
"A new generation of bold, innovative healthcare leaders is making healthcare more accessible, affordab...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US6283411097
Oncotelic Therapeutics, Inc.
OTLC
LISTED
OTC
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Building Breakthrough Portfolio Aimed at Transforming Cancer, Rare Disease Treatments
News Preview
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and cont...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US18914F1030
Clover Health Investments Corp
CLOV
LISTED
NASDAQ
Clover Health Launches New Portal Availity® Essentials™ to Empower Providers and Improve the Patient Experience
News Preview
Clover Health Continues to Invest in Streamlining Provider Workflows and Reducing Administrative Burden Through Technology and Operational Improvements Clover Health Continues to Invest in Streamlining Provider Workflows and Reducing Administrative Burden Through Technology and Operational Improvements...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: CA22587M1068
Cresco Labs Inc
CL
LISTED
CSE
Cresco Labs Opens Sunnyside Proctorville, Strengthening Ohio Market Leadership
News Preview
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside in Proctorville, Ohio. It is the Company’s sixth dispensary in Ohio and 71st nationwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250916774840/en/...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US82711P2011
Silo Pharma, Inc.
SILO
LISTED
NASDAQ
Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy
News Preview
Strategic capital deployment advances Company’s blockchain treasury model and biopharma development initiatives...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US05280R1005
Autolus Therapeutics plc
AUTL
LISTED
NASDAQ
Autolus Therapeutics to Present Clinical Data Update at the American College of Rheumatology (ACR) Convergence 2025
News Preview
Autolus announces the publication of an abstract submitted to the American College of Rheumatology (ACR) Convergence 2025, to be held October 24-29, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: ES0167733015
Oryzon Genomics SA
ORY
LISTED
BME
ORYZON Strengthens Patent Portfolio for Iadademstat and Vafidemstat with New Decisions to Grant
News Preview
In Australia and Europe In Australia and Europe...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US00688A2050
Adial Pharmaceuticals Inc
ADIL
LISTED
NASDAQ
Adial Pharmaceuticals Provides Business Update Following Favorable Comments from FDA End-of-Phase 2 (EOP2) Meeting for AD04
News Preview
FDA Minutes Reflect Constructive Dialogue and Successful Meeting Outcome with Alignment on Upcoming Phase 3 Clinical Trial Design for AD04 In Alcohol Use Disorder FDA Minutes Reflect Constructive Dialogue and Successful Meeting Outcome with Alignment on Upcoming Phase 3 Clinical Trial Design for AD04 In Alcohol Use Disorder...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US21833P3010
Corbus Pharmaceuticals Holdings Inc
CRBP
LISTED
NASDAQ
FDA Grants Fast Track Designation to Corbus Pharmaceuticals’ Nectin-4 Targeting ADC CRB-701 in Head and Neck Squamous Cell Carcinoma
News Preview
NORWOOD, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage oncology and obesity company, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CRB-701 for the treatment of recurrent or metastatic head and nec...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US05479K1060
Elutia Inc
AZYO
LISTED
NASDAQ
Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation
News Preview
- Findings highlight the potential of antibiotic-eluting bioenvelopes to transform cardiac implantable electronic device (CIED) pocket management -...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: CA46604F1099
Izotropic Corporation
IZO
LISTED
CSE
Izotropic Publishes New FAQ Page for Investors, Analysts, and Healthcare Decision-Makers
News Preview
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- via IBN –Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US05337M1045
Avadel Pharmaceuticals plc
AVDL
LISTED
NASDAQ
Avadel Pharmaceuticals Celebrates Five Years of Driving Growth in Sleep Research Funding
News Preview
A Media Snippet accompanying this announcement is available by clicking on this link....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US70261F1030
Pasithea Therapeutics Corp.
KTTA
LISTED
NASDAQ
Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
News Preview
Pasithea Tx (Nasdaq: KTTA) activates South Korea trial sites, dosing first NF1 patient in Phase 1/1b NF1 study at Asan Medical Ctr. and Severance Hospital....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US4169061052
Harvard Bioscience Inc
HBIO
LISTED
NASDAQ
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
News Preview
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US09077A1060
Biomea Fusion Inc
BMEA
LISTED
NASDAQ
Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update
News Preview
SAN CARLOS, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Biomea or Biomea Fusion) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced the presentation of preclinical data from its investigational menin inhibitor icovamenib in combination with semaglutide in a T2D animal model. The oral pres...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Hop Valley Brewing and Oregon Athletics Announce the Launch of Dang Green IPA, the First Official Craft Beer for the Oregon Ducks
News Preview
EUGENE, Ore., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Hop Valley Brewing Co. (“Hop Valley Brewing” or “Hop Valley”), a trailblazer in the craft brewing industry and brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a leading global lifestyle and consumer packaged goods company, together with Oregon Athletics, are excited to announce the relea...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US30233G2093
EyePoint Pharmaceuticals Inc
EYPT
LISTED
NASDAQ
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
WATERTOWN, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outsi...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US88032L6056
Tenax Therapeutics, Inc.
TENX
LISTED
NASDAQ
Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF
News Preview
Provides Patent Protection in Europe Through at Least December 2040...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US9250501064
Verona Pharma plc
VRNA
LISTED
NASDAQ
Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025
News Preview
Posters support Ohtuvayre® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and PDE4 for a broad COPD population...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme
News Preview
Bagsværd, Denmark, 16 September 2025 – Novo Nordisk today presented data from a sub-analysis of the phase 3 REDEFINE 1 trial at the European Association for the Study of Diabetes (EASD) congress 2025 from 15–19 September in Vienna, Austria. This sub-analysis evaluated the efficacy and safety of once-weekly cagrilintide 2.4 mg monotherapy, plus life...
Themefolio
Profiler
Peergroup
© Newsfile
16.09.2025
ISIN: CA24463V1013
Defence Therapeutics Inc.
DTC
LISTED
CSE
Defence Therapeutics Appoints Dr. Amie Phinney as Director
News Preview
Montreal, Quebec--(Newsfile Corp. - September 16, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce the appointment of Dr. Amie Phinney, PhD, MBA to its Board of Directors, effective immediately.D...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.09.2025
ISIN: US03835L2079
Aptevo Therapeutics Inc.
APVO
LISTED
NASDAQ
Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML
News Preview
No dose-limiting toxicities or cytokine release syndrome observed in RAINIER to date; mipletamig shows consistently favorable safety and tolerabilityTrial progressing efficiently, Cohort 4 open for enrollment SEATTLE, WA / ACCESS Newswire / September 16, 2025 / Aptevo Therapeutics ("Aptevo" or "the Company") (NASDAQ:APVO), a cli...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.09.2025
ISIN: US7389201077
Aspire Biopharma Holdings, Inc
ASBP
LISTED
NASDAQ
Aspire Biopharma Announces Initial Production Order of Two Million Servings (100,000 20-packs) of BUZZ BOMB(TM) Pre-Workout Supplement
News Preview
Part of New Contract Manufacturing Agreement with SupraNaturals to Secure Additional Production CapacitySupraNaturals is a leading private label manufacturer in the health and wellness industryBUZZ BOMB™ pre-workout:50mg caffeine for energy and focus.Boosts performance potential.Stick packs:Convenient, no water needed.Precise caffeine doseGlo...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.09.2025
ISIN: US60458C1045
Mira Pharmaceuticals Inc
MIRA
LISTED
NASDAQ
MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals
News Preview
MIRA advances Ketamir-2 in the clinic for neuropathic pain while broadening development into neuropsychiatric disorders such as PTSD MIAMI, FLORIDA / ACCESS Newswire / September 16, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel oral therapeutic...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
